CN Patent

CN115894376B — 一种芳香族酰胺类化合物、药物组合物及其用途

Assigned to Nanjing Leizheng Pharmaceutical Technology Co ltd · Expires 2025-05-16 · 1y expired

What this patent protects

本发明公开了一种芳香族酰胺类化合物、药物组合物及其用途，属于化学医药领域。本发明提供一种如通式(I)所示结构的芳香族酰胺类化合物及其药学上可接受的盐，可用作布鲁顿酪氨酸激酶(BTK)抑制剂，以及基于BTK抑制作用可用于预防和/或治疗癌症。

USPTO Abstract

本发明公开了一种芳香族酰胺类化合物、药物组合物及其用途，属于化学医药领域。本发明提供一种如通式(I)所示结构的芳香族酰胺类化合物及其药学上可接受的盐，可用作布鲁顿酪氨酸激酶(BTK)抑制剂，以及基于BTK抑制作用可用于预防和/或治疗癌症。

Drugs covered by this patent

Patent Metadata

Patent number: CN115894376B
Jurisdiction: CN
Classification: —
Expires: 2025-05-16
Drug substance claim: No
Drug product claim: No
Assignee: Nanjing Leizheng Pharmaceutical Technology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.